Following people with jaw bone damage linked to certain medicines
Follows adults with medication-related osteonecrosis of the jaw to see what affects recovery.
Key facts
- Who runs it
- Marmara University
- Where
- Türkiye1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Therapeutic Exposures and Risk Factors in MRONJ
- Status
- Recruiting
- People taking part
- 250 people, planned
- Started
- 25 Apr 2024
- Expected to end
- 26 Apr 2027
- Type of study
- Observational
- Record updated
- 28 May 2024
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with jaw bone damage caused by medicines (MRONJ). They must come to the Marmara University Faculty of Dentistry, Department of Oral and Maxillofacial Surgery during the study period.
- Age
- 18 Years to 110 Years
- Sex
- All sexes can join
- Disease stage
- Medication-related osteonecrosis of the jaw: jaw bone damage linked to certain medicines.
Main reasons for not taking part
- Jaw bone damage or bone infection not caused by medicines
- Jaw bone damage caused by radiation (osteoradionecrosis)
- Cancer that has spread to the mouth area
- No written consent from the person or their legal representative
- Under 18 years of age
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Individuals aged 18 and over
- Male or female individuals
- Individuals who apply to the Marmara University Faculty of Dentistry, Department of Oral and Maxillofacial Surgery due to medication-related osteonecrosis of jaw during the study period
- Individuals or their legal representatives who have given written consent to participate in the study
Who cannot take part
- Non-drug-related osteonecrosis/osteomyelitis
- Individuals under the age of 18
- Osteoradionecrosis
- Metastasis to the oral region
- Individuals who have not given written consent to participate in the study
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 18 and 110 years old?
This trial is currently available in Türkiye.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study focuses on patients who have developed a condition called medication-related osteonecrosis of the jaw (MRONJ), which can occur after using certain medications. The purpose is to closely monitor these patients over time to better understand how they are diagnosed, treated, and followed up. By doing this, researchers hope to uncover how different factors such as a patient's background, lifestyle, and other health conditions might influence their recovery and overall quality of life.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Identification of Therapeutic Exposures and Risk Factors Associated With Medication-Related Osteonecrosis of the Jaw
- Plain-language title
- Following people with jaw bone damage linked to certain medicinesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Criteria questions
- Built from NCT06430762, who can take part
- Record updated
- 28 May 2024